These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 6741200)
41. [Inhibition of H+/K+-ATPase in the parietal cell with omeprazole: a new principle of gastric acid inhibition]. Lamers CB Ned Tijdschr Geneeskd; 1985 Apr; 129(15):679-82. PubMed ID: 2986019 [No Abstract] [Full Text] [Related]
42. Pharmacological properties of the gastric H(+)/K(+) ATPase inhibitor, AU-461. Cheon HG; Kim HJ; Mo HK; Lee BH; Choi J Pharmacology; 2000 Apr; 60(3):161-8. PubMed ID: 10754453 [TBL] [Abstract][Full Text] [Related]
43. [Acid secretion and hormone levels after several weeks of omeprazole administration]. Müller P; Simon B; Dammann HG; Feurle G; Huefner M; Rabe T Dtsch Med Wochenschr; 1983 Nov; 108(47):1816. PubMed ID: 6641533 [No Abstract] [Full Text] [Related]
44. Gastric acid secretion and duodenal ulcer healing during treatment with omeprazole. A Scandinavian Multicentre Study. Scand J Gastroenterol; 1984 Oct; 19(7):882-4. PubMed ID: 6397846 [TBL] [Abstract][Full Text] [Related]
45. A comparative pharmacodynamic study of IY-81149 versus omeprazole in patients with gastroesophageal reflux disease. Periclou AP; Goldwater R; Lee SM; Park DW; Kim DY; Cho KD; Boileau F; Jung WT Clin Pharmacol Ther; 2000 Sep; 68(3):304-11. PubMed ID: 11014412 [TBL] [Abstract][Full Text] [Related]
47. Gastric acid antisecretory effect of two different dosage forms of omeprazole during prolonged oral treatment in the gastric fistula dog. Larsson H; Mattsson H; Carlsson E Scand J Gastroenterol; 1988 Oct; 23(8):1013-9. PubMed ID: 3201125 [TBL] [Abstract][Full Text] [Related]
52. Effect of single and repeated doses of oral omeprazole on gastric acid and pepsin secretion and fasting serum gastrin and serum pepsinogen I levels. Festen HP; Tuynman HA; Défize J; Pals G; Frants RR; Straub JP; Meuwissen SG Dig Dis Sci; 1986 Jun; 31(6):561-6. PubMed ID: 3086061 [TBL] [Abstract][Full Text] [Related]
53. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome. Clissold SP; Campoli-Richards DM Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658 [TBL] [Abstract][Full Text] [Related]
54. [4 weeks' administration of omeprazole: effect on acid behavior and basal hormone levels]. Müller P; Seitz HK; Simon B; Dammann HG; Feurle G; Huefner M; Lichtwald K; Schmidt-Gayk H Z Gastroenterol; 1984 May; 22(5):236-40. PubMed ID: 6741200 [TBL] [Abstract][Full Text] [Related]
55. [Behavior of acid secretion under the long-term daily administration of omeprazol]. Dammann HG; Müller P; Seitz HK; Simon B Schweiz Med Wochenschr; 1983 Jun; 113(24):895-8. PubMed ID: 6348940 [TBL] [Abstract][Full Text] [Related]
56. The effect of omeprazole on insulin induced gastric secretion in man. Utley RJ; Wright R; Beastall GH; Carter DC Scott Med J; 1985 Apr; 30(2):96-100. PubMed ID: 3892679 [TBL] [Abstract][Full Text] [Related]